Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells

Molecular Therapy: Nucleic Acids · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles